BRAVACCINI, SARA
BRAVACCINI, SARA
Dipartimento di Medicina e Chirurgia
A functional survey of the regulatory landscape of estrogen-receptor-positive breast cancer evolution
2024-01-01 Barozzi, I; Slaven, N; Canale, E; Lopes, R; Amorim Monteiro Barbosa, I; Bleu, M; Ivanoiu, D; Pacini, C; Mensa, E; Chambers, A; Bravaccini, S; Ravaioli, S; Gyorffy, B; Dieci, Mv; Pruneri, G; Galli, Gg; Magnani, L
Androgen receptor in breast cancer: The "5W" questions
2022-01-01 Ravaioli, S; Maltoni, R; Pasculli, B; Parrella, P; Giudetti, Am; Vergara, D; Tumedei, Mm; Pirini, F; Bravaccini, S
Androgen receptor signaling pathways as a target for breast cancer treatment
2016-01-01 Pietri, E; Conteduca, V; Andreis, D; Massa, I; Melegari, E; Sarti, S; Cecconetto, L; Schirone, A; Bravaccini, S; Serra, P; Fedeli, A; Maltoni, R; Amadori, D; De Giorgi, U; Rocca, A
Appropriateness and Economic Analysis of Conventional Circulating Biomarkers Assessment in Early Breast Cancer: A Real-World Experience from the E.Pic.A Study
2022-01-01 Maltoni, R; Balzi, W; Rossi, T; Fabbri, F; Bravaccini, S; Montella, Mt; Massa, I; Bertoni, L; Falcini, F; Altini, M
Are Androgen and Estrogen Receptors in DCIS Patients Prognostic Indicators of Relapse Independently of Treatment?
2019-01-01 Ravaioli, S; Puccetti, M; Tumedei, Mm; Silvestrini, R; Bedei, L; Bravaccini, S
Are BMI and Negative Hormone Receptors Prognostic Factors in HER2+ Early-stage Breast Cancer?
2020-01-01 Maltoni, R.; Palleschi, M.; Altini, M.; Massa, I.; Balzi, W.; Ravaioli, S.; Tumedei, M. M.; Rocca, A.; Bravaccini, S.
Are fine-needle aspiration biopsy-derived cell blocks a useful surrogate for tissue samples in breast cancer?
2018-01-01 Puccetti, M; Ravaioli, S; Tumedei, Mm; Bucchi, E; Malmesi, M; Medri, L; Bravaccini, S
Are There Differences in Androgen Receptor Expression in Invasive Breast Cancer in African (Tanzanian) Population in Comparison With the Caucasian (Italian) Population?
2018-01-01 Bravaccini, S; Ravaioli, S; Amadori, D; Scarpi, E; Puccetti, M; Rocca, A; Tumedei, Mm; Masalu, N; Kahima, J; Pangan, A; Faustine, L; Farolfi, A; Maltoni, R; Bonafe, M; Serra, P; Bronte, G
Are we ready to use TMB in breast cancer clinical practice?
2020-01-01 Ravaioli, S.; Limarzi, F.; Tumedei, M. M.; Palleschi, M.; Maltoni, R.; Bravaccini, S.
Assessment of DNA Damage and Telomerase Activity in Exfoliated Urinary Cells as Sensitive and Noninvasive Biomarkers for Early Diagnosis of Bladder Cancer in Ex-Workers of a Rubber Tyres Industry
2014-01-01 Cavallo, D; Casadio, V; Bravaccini, S; Iavicoli, S; Pira, E; Romano, C; Fresegna, Am; Maiello, R; Ciervo, A; Buresti, G; Zoli, W; Calistri, D
Atezolizumab Plus Nab-paclitaxel in PD-L1-Positive TNBC-Letter
2020-01-01 Bravaccini, S; Ravaioli, S; Tumedei, Mm; Rocca, A; Palleschi, M; Puccetti, M; Parrella, P; Altini, M; Maltoni, R
Benefit from anthracyclines in relation to biological profiles in early breast cancer
2014-01-01 Rocca, A; Bravaccini, S; Scarpi, E; Mangia, A; Petroni, S; Puccetti, M; Medri, L; Serra, L; Ricci, M; Cerasoli, S; Biglia, N; Maltoni, R; Giunchi, Dc; Gianni, L; Tienghi, A; Brandi, M; Faedi, M; Sismondi, P; Paradiso, A; Silvestrini, R; Amadori, D
Biofunctional characteristics of in situ and invasive breast carcinoma
2013-01-01 Bravaccini, S; Granato, Am; Medri, L; Foca, F; Falcini, F; Zoli, W; Ricci, M; Lanzanova, G; Masalu, N; Serra, L; Buggi, F; Folli, S; Silvestrini, R; Amadori, D
CAR T cells targeting options in the fight against multiple myeloma
2021-01-01 Nicolini, F; Bravaccini, S; Mazza, M; Gruszka, Am; Tazzari, M; Martin-Antonio, B; Juan, M; Ibrahim, T; Maltoni, R; Martinelli, G; Cerchione, C
Carbonic Anhydrase XII Expression Is Modulated during Epithelial Mesenchymal Transition and Regulated through Protein Kinase C Signaling
2020-01-01 Vergara, D; Ravaioli, S; Fonzi, E; Adamo, L; Damato, M; Bravaccini, S; Pirini, F; Gaballo, A; Barbano, R; Pasculli, B; Franck, J; Fournier, I; Salzet, M; Maffia, M
CD68, CD163, and matrix metalloproteinase 9 (MMP-9) in breast tumor microenvironment to predict breast cancer survival: are they enough?
2019-01-01 Bravaccini, S; Maltoni, R
Cell-free DNA detected by "liquid biopsy" as a potential prognostic biomarker in early breast cancer
2017-01-01 Maltoni, R; Casadio, V; Ravaioli, S; Foca, F; Tumedei, Mm; Salvi, S; Martignano, F; Calistri, D; Rocca, A; Schirone, A; Amadori, D; Bravaccini, S
Chimeric Antigen Receptor T-Cell Therapy: What We Expect Soon
2022-01-01 Martino, M; Naso, V; Loteta, B; Canale, Fa; Pugliese, M; Alati, C; Musuraca, G; Nappi, D; Gaimari, A; Nicolini, F; Mazza, M; Bravaccini, S; Derudas, D; Martinelli, G; Cerchione, C
Clinical utility of fulvestrant in the treatment of breast cancer: a report on the emerging clinical evidence
2018-01-01 Rocca, A; Maltoni, R; Bravaccini, S; Donati, C; Andreis, D
Combined analysis of miR-200 family and its significance for breast cancer
2021-01-01 Fontana, A; Barbano, R; Dama, E; Pasculli, B; Rendina, M; Morritti, Mg; Melocchi, V; Castelvetere, M; Valori, Vm; Ravaioli, S; Bravaccini, S; Ciuffreda, L; Graziano, P; Maiello, E; Copetti, M; Fazio, Vm; Esteller, M; Bianchi, F; Parrella, P
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
A functional survey of the regulatory landscape of estrogen-receptor-positive breast cancer evolution | 1-gen-2024 | Barozzi, I; Slaven, N; Canale, E; Lopes, R; Amorim Monteiro Barbosa, I; Bleu, M; Ivanoiu, D; Pacini, C; Mensa, E; Chambers, A; Bravaccini, S; Ravaioli, S; Gyorffy, B; Dieci, Mv; Pruneri, G; Galli, Gg; Magnani, L | |
Androgen receptor in breast cancer: The "5W" questions | 1-gen-2022 | Ravaioli, S; Maltoni, R; Pasculli, B; Parrella, P; Giudetti, Am; Vergara, D; Tumedei, Mm; Pirini, F; Bravaccini, S | |
Androgen receptor signaling pathways as a target for breast cancer treatment | 1-gen-2016 | Pietri, E; Conteduca, V; Andreis, D; Massa, I; Melegari, E; Sarti, S; Cecconetto, L; Schirone, A; Bravaccini, S; Serra, P; Fedeli, A; Maltoni, R; Amadori, D; De Giorgi, U; Rocca, A | |
Appropriateness and Economic Analysis of Conventional Circulating Biomarkers Assessment in Early Breast Cancer: A Real-World Experience from the E.Pic.A Study | 1-gen-2022 | Maltoni, R; Balzi, W; Rossi, T; Fabbri, F; Bravaccini, S; Montella, Mt; Massa, I; Bertoni, L; Falcini, F; Altini, M | |
Are Androgen and Estrogen Receptors in DCIS Patients Prognostic Indicators of Relapse Independently of Treatment? | 1-gen-2019 | Ravaioli, S; Puccetti, M; Tumedei, Mm; Silvestrini, R; Bedei, L; Bravaccini, S | |
Are BMI and Negative Hormone Receptors Prognostic Factors in HER2+ Early-stage Breast Cancer? | 1-gen-2020 | Maltoni, R.; Palleschi, M.; Altini, M.; Massa, I.; Balzi, W.; Ravaioli, S.; Tumedei, M. M.; Rocca, A.; Bravaccini, S. | |
Are fine-needle aspiration biopsy-derived cell blocks a useful surrogate for tissue samples in breast cancer? | 1-gen-2018 | Puccetti, M; Ravaioli, S; Tumedei, Mm; Bucchi, E; Malmesi, M; Medri, L; Bravaccini, S | |
Are There Differences in Androgen Receptor Expression in Invasive Breast Cancer in African (Tanzanian) Population in Comparison With the Caucasian (Italian) Population? | 1-gen-2018 | Bravaccini, S; Ravaioli, S; Amadori, D; Scarpi, E; Puccetti, M; Rocca, A; Tumedei, Mm; Masalu, N; Kahima, J; Pangan, A; Faustine, L; Farolfi, A; Maltoni, R; Bonafe, M; Serra, P; Bronte, G | |
Are we ready to use TMB in breast cancer clinical practice? | 1-gen-2020 | Ravaioli, S.; Limarzi, F.; Tumedei, M. M.; Palleschi, M.; Maltoni, R.; Bravaccini, S. | |
Assessment of DNA Damage and Telomerase Activity in Exfoliated Urinary Cells as Sensitive and Noninvasive Biomarkers for Early Diagnosis of Bladder Cancer in Ex-Workers of a Rubber Tyres Industry | 1-gen-2014 | Cavallo, D; Casadio, V; Bravaccini, S; Iavicoli, S; Pira, E; Romano, C; Fresegna, Am; Maiello, R; Ciervo, A; Buresti, G; Zoli, W; Calistri, D | |
Atezolizumab Plus Nab-paclitaxel in PD-L1-Positive TNBC-Letter | 1-gen-2020 | Bravaccini, S; Ravaioli, S; Tumedei, Mm; Rocca, A; Palleschi, M; Puccetti, M; Parrella, P; Altini, M; Maltoni, R | |
Benefit from anthracyclines in relation to biological profiles in early breast cancer | 1-gen-2014 | Rocca, A; Bravaccini, S; Scarpi, E; Mangia, A; Petroni, S; Puccetti, M; Medri, L; Serra, L; Ricci, M; Cerasoli, S; Biglia, N; Maltoni, R; Giunchi, Dc; Gianni, L; Tienghi, A; Brandi, M; Faedi, M; Sismondi, P; Paradiso, A; Silvestrini, R; Amadori, D | |
Biofunctional characteristics of in situ and invasive breast carcinoma | 1-gen-2013 | Bravaccini, S; Granato, Am; Medri, L; Foca, F; Falcini, F; Zoli, W; Ricci, M; Lanzanova, G; Masalu, N; Serra, L; Buggi, F; Folli, S; Silvestrini, R; Amadori, D | |
CAR T cells targeting options in the fight against multiple myeloma | 1-gen-2021 | Nicolini, F; Bravaccini, S; Mazza, M; Gruszka, Am; Tazzari, M; Martin-Antonio, B; Juan, M; Ibrahim, T; Maltoni, R; Martinelli, G; Cerchione, C | |
Carbonic Anhydrase XII Expression Is Modulated during Epithelial Mesenchymal Transition and Regulated through Protein Kinase C Signaling | 1-gen-2020 | Vergara, D; Ravaioli, S; Fonzi, E; Adamo, L; Damato, M; Bravaccini, S; Pirini, F; Gaballo, A; Barbano, R; Pasculli, B; Franck, J; Fournier, I; Salzet, M; Maffia, M | |
CD68, CD163, and matrix metalloproteinase 9 (MMP-9) in breast tumor microenvironment to predict breast cancer survival: are they enough? | 1-gen-2019 | Bravaccini, S; Maltoni, R | |
Cell-free DNA detected by "liquid biopsy" as a potential prognostic biomarker in early breast cancer | 1-gen-2017 | Maltoni, R; Casadio, V; Ravaioli, S; Foca, F; Tumedei, Mm; Salvi, S; Martignano, F; Calistri, D; Rocca, A; Schirone, A; Amadori, D; Bravaccini, S | |
Chimeric Antigen Receptor T-Cell Therapy: What We Expect Soon | 1-gen-2022 | Martino, M; Naso, V; Loteta, B; Canale, Fa; Pugliese, M; Alati, C; Musuraca, G; Nappi, D; Gaimari, A; Nicolini, F; Mazza, M; Bravaccini, S; Derudas, D; Martinelli, G; Cerchione, C | |
Clinical utility of fulvestrant in the treatment of breast cancer: a report on the emerging clinical evidence | 1-gen-2018 | Rocca, A; Maltoni, R; Bravaccini, S; Donati, C; Andreis, D | |
Combined analysis of miR-200 family and its significance for breast cancer | 1-gen-2021 | Fontana, A; Barbano, R; Dama, E; Pasculli, B; Rendina, M; Morritti, Mg; Melocchi, V; Castelvetere, M; Valori, Vm; Ravaioli, S; Bravaccini, S; Ciuffreda, L; Graziano, P; Maiello, E; Copetti, M; Fazio, Vm; Esteller, M; Bianchi, F; Parrella, P |